Shop Talk

You have full text access to this OnlineOpen article

Shop talk: Sugars, bones, and a disease called multiple hereditary exostoses†

  1. Henry H. Roehl1,*,
  2. Maurizio Pacifici2

Article first published online: 9 APR 2010

DOI: 10.1002/dvdy.22290

Issue

Developmental Dynamics

Developmental Dynamics

Volume 239, Issue 6, pages 1901–1904, June 2010

Additional Information

How to Cite

Roehl, H. H. and Pacifici, M. (2010), Shop talk: Sugars, bones, and a disease called multiple hereditary exostoses. Dev. Dyn., 239: 1901–1904. doi: 10.1002/dvdy.22290

Author Information

  1. 1

    MRC Centre for Developmental and Biomedical Genetics, University of Sheffield, Sheffield, United Kingdom

  2. 2

    Department of Orthopaedic Surgery, Thomas Jefferson University, School of Medicine, Philadelphia, Pennsylvania

*MRC Centre for Developmental and Biomedical Genetics, Firth Court, Western Bank, University of Sheffield, Sheffield S10 2TN, UK

  1. †

    Multiple hereditary exostoses (MHE) is also known a hereditary multiple exostoses, osteochondromatosis, or diaphyseal aclasis, depending primarily upon the geographic location. It was renamed to multiple osteochondroma by the World Health Organisation in 2002; however, the renaming remains controversial, and many researchers as well as patients and their families prefer to use the original designation. This issue was discussed at the Third International MHE Research Conference, but a consensus was unfortunately not reached.

Publication History

  1. Issue published online: 17 MAY 2010
  2. Article first published online: 9 APR 2010
  3. Manuscript Accepted: 4 MAR 2010

Funded by

  • Wellcome Trust. Grant Number: 072346/Z/03/Z

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (147K)

Keywords:

  • cartilage;
  • bone;
  • tumor;
  • exostoses;
  • osteochondroma;
  • heparan sulfate

Abstract

On October 29, 2009, researchers and physicians gathered at the Sheraton Four Points Hotel in Boston for 4 days to discuss a disease called multiple hereditary exostoses (MHE). MHE is an autosomal dominant disease that is associated with mutations in two enzymes that are required for heparan sulfate (HS) synthesis. Children with the disease form numerous benign bone tumors (osteochondromas) and have >2% chance of developing chondrosarcoma. The aim of the meeting was to generate new ideas for the diagnoses, treatment, and cure of this disease. Discussions ranged from orthopedic surgical treatment and patients' personal experiences to fundamental questions in skeletal biology and the precise molecular role that HS plays in developmental signaling pathways. Developmental Dynamics 239:1901–1904, 2010. © 2010 Wiley-Liss, Inc.

View Full Article (HTML) Get PDF (147K)